www.fdanews.com/articles/82092-accentia-biopharmaceuticals-announces-pricing-of-initial-public-offering
ACCENTIA BIOPHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
November 1, 2005
Accentia Biopharmaceuticals, Inc. announced today the pricing of its initial
public offering of 2,400,000 shares of its common stock at a price to the public
of $8.00 per share. All of the shares are being offered by Accentia. In addition,
Accentia has granted to the underwriters a 30-day option to purchase up to an
additional 360,000 shares to cover over-allotments, if any. Accentia's common
stock will be listed on the Nasdaq National Market under the symbol "ABPI."
The offering is expected to close on November 2, 2005.
Business
Wire